BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
1385 results:

  • 1. [A Case of Distal Gastrectomy and Left Segmentectomy for Hepatic Invasion of Gastric cancer].
    Nakayama Y; Koyama K; Shimizu K; Kanemoto R; Urata N; Komori K; Uchiyama M; Suzuki Y; Rino Y; Saito A
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):457-459. PubMed ID: 38644321
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [A Case of Stage Ⅳ Gastric cancer with Multiple liver Metastases, Resected Primary Tumor after Chemotherapy, and Alive for 3.5 Years without Recurrence].
    Nakagawa T; Yamamoto Y; Yanagawa S; Shiozaki S; Kaneko Y; Watanabe A; Nishina M; Takei D; Sumi Y; Yamaki M; Kurayoshi M; Hashizume J; Oshita A; Nakahara M; Noriyuki T
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):433-435. PubMed ID: 38644313
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)].
    Trastuzumab Deruxtecan Clinical Management Pathway and Adverse Reaction Management Consensus Expert Group
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):304-318. PubMed ID: 38644266
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
    Chen X; Mohammed AF; Li C
    Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting Breast cancer Using 177 Lu-Labeled Trastuzumab and Trastuzumab Fragment : First-in-Human Clinical Experience.
    Rathore Y; Lakhanpal T; Chakraborty S; Chakravarty R; Mittal BR; Irrinki RNS; Laroiya I; Kaur K; Shukla J
    Clin Nucl Med; 2024 Jun; 49(6):e258-e265. PubMed ID: 38579266
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins
    Larkina M; Varvashenya R; Yuldasheva F; Plotnikov E; Bezverkhniaia E; Tretyakova M; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Belousov M; Orlova A; Tolmachev V; Deyev S
    Mol Pharm; 2024 Apr; 21(4):1919-1932. PubMed ID: 38557163
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Human Epidermal Growth Factor Receptor 2 (her2) PET Imaging of her2-Low Breast cancer with [
    Altena R; Burén SA; Blomgren A; Karlsson E; Tzortzakakis A; Brun N; Moein MM; Jussing E; Frejd FY; Bergh J; Tran TA; Hartman J; Axelsson R
    J Nucl Med; 2024 May; 65(5):700-707. PubMed ID: 38548353
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discussing the safety and effectiveness of transcatheter arterial embolization combined with intravenous chemotherapy in treating locally advanced breast cancer.
    Zhang J; Zhang J; Niu X; Zhou Y; Guo Y; Wang Y; Shou F
    Sci Rep; 2024 Mar; 14(1):6003. PubMed ID: 38472493
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, her2-negative metastatic breast cancer: A real-world multicenter study.
    Li D; Jin Y; Lin M; Zeng C; Guo Q; Liu Y; Zhang J
    Cancer Med; 2024 Feb; 13(4):e6762. PubMed ID: 38457252
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
    Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
    Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular Characterization and Subtyping of Breast cancer Cell Lines Provide Novel Insights into cancer Relevant Genes.
    Pommerenke C; Nagel S; Haake J; Koelz AL; Christgen M; Steenpass L; Eberth S
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391914
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in her2-Positive Metastatic and Locally Advanced Breast Carcinoma.
    Narwadkar YS; Parghane RV; Sahu S; Lad S; Deep K; Wanage G; Suralkar T; Banerjee S; Gupta S; Basu S; Badwe RA
    Clin Nucl Med; 2024 Apr; 49(4):e149-e155. PubMed ID: 38350067
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.
    Gou M; Zhang Y; Wang Z; Qian N; Dai G
    Invest New Drugs; 2024 Apr; 42(2):171-178. PubMed ID: 38347177
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [A Case of Advanced Recurrent Rectal cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug].
    Sakuma T; Shibutani M; Fukuoka T; Kasashima H; Nishiyama M; Fukui Y; Natsuki S; Nishiyama T; Maruo K; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1504-1506. PubMed ID: 38303322
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [A Case of Postoperative Recurrence of Bilateral Breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
    Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A Case of liver Metastasis of Gastric cancer Successfully Treated with SOX plus Nivolumab].
    Ueno M; Endo S; Hori M; Kageyama C; Iwamoto R; Kinoshita S; Kitagawa S; Mineta S; Kanesada K; Higashida M; Ito Y; Okada T; Yoshimatsu K; Fujiwara Y; Ueno T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1813-1815. PubMed ID: 38303216
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [A Case of her2-Positive Advanced Gastric cancer with liver Metastasis Treated by Laparoscopic Surgery after Chemotherapy and Achieved Pathological Complete Response].
    Shimizu K; Tsuchida K; Mizutani M; Sakaguchi Y; Sahara K; Miyake M; Segami K; Shirai J; Ueda M; Mushiake H; Hasegawa S; Fukushima T; Nakayama T; Rino Y; Saito A
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1801-1803. PubMed ID: 38303212
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
    Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [A Case of her2-Positive Advanced Breast cancer Who Was Able to Start and Continue Chemotherapy Despite liver Damage Due to Diffuse liver Metastasis].
    Fujimoto T; Maeda N; Ioka T; Nagano H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1739-1741. PubMed ID: 38303191
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A Case of Recurrent Gastric cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
    Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 70.